open access

Vol 14, No 4 (2019)
Heart failure
Get Citation

Empagliflozin in heart failure — new facts. Commentary on the article: Cessation of empagliflozin treatment in a hospitalised patient with exacerbated heart failure and reduced ejection fraction. Folia Cardiol. 2019; 14(2): 199–205

Małgorzata Lelonek
Folia Cardiologica 2019;14(4):420-421.

open access

Vol 14, No 4 (2019)
Heart failure

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Empagliflozin in heart failure — new facts. Commentary on the article: Cessation of empagliflozin treatment in a hospitalised patient with exacerbated heart failure and reduced ejection fraction. Folia Cardiol. 2019; 14(2): 199–205

Journal

Folia Cardiologica

Issue

Vol 14, No 4 (2019)

Pages

420-421

Bibliographic record

Folia Cardiologica 2019;14(4):420-421.

Authors

Małgorzata Lelonek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl